Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different neuroprotective effect.
Ebru
E
Parlayan
Burak
B
Yulug
Mustafa
M
Bakar
Oguzhan
O
Gumustas
D000368:Aged; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D003072:Cognition Disorders / Q000188:drug therapy / Q000378:metabolism; D003704:Dementia / Q000188:drug therapy* / Q000378:metabolism; D000077265:Donepezil; D005260:Female; D006801:Humans; D007189:Indans / Q000494:pharmacology*; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009483:Neuropsychological Tests; D048448:Phenylcarbamates / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D011569:Psychiatric Status Rating Scales; D000068836:Rivastigmine; D016896:Treatment Outcome
D007189:Indans; D018696:Neuroprotective Agents; D048448:Phenylcarbamates; D010880:Piperidines; D001224:Aspartic Acid; D000077265:Donepezil; C000179:N-acetylaspartate; D000068836:Rivastigmine